                         SEQUENCE LISTING

<110>  Purdue Research Foundation
 
<120>  NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE
        OF THEREOF

<130>  68665-02

<140>  PCT/US22/19222
<141>  2022-03-08

<150>  US 63/160,035
<151>  2021-03-12

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein/Peptide 85B

<400>  1

Met Phe Gln Asp Ala Tyr Asn Ala Ala Gly Gly His Asn Ala Val Phe 
1               5                   10                  15      


Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val 
            20                  25                  30          


Glu Glu Asn Pro Gly 
        35          


<210>  2
<211>  59
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein/Peptide 85B-C5

<400>  2

Met Phe Gln Asp Ala Tyr Asn Ala Ala Gly Gly His Asn Ala Val Phe 
1               5                   10                  15      


Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val 
            20                  25                  30          


Glu Glu Asn Pro Gly Pro Ala Ala Gln Ala Ala Val Val Arg Phe Gln 
        35                  40                  45              


Glu Ala Ala Asn Lys Gln Lys Gln Glu Leu Asp 
    50                  55                  


<210>  3
<211>  1101
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  [0021]	DNA sequences of the CMV promoter, 85B epitope, peptide 
       2A, and BGH polyadenylation signal

<400>  3
gacattgatt attgactagt tattaatagt aatcaattac ggggtcatta gttcatagcc       60

catatatgga gttccgcgtt acataactta cggtaaatgg cccgcctggc tgaccgccca      120

acgacccccg cccattgacg tcaataatga cgtatgttcc catagtaacg ccaataggga      180

ctttccattg acgtcaatgg gtggactatt tacggtaaac tgcccacttg gcagtacatc      240

aagtgtatca tatgccaagt acgcccccta ttgacgtcaa tgacggtaaa tggcccgcct      300

ggcattatgc ccagtacatg accttatggg actttcctac ttggcagtac atctacgtat      360

tagtcatcgc tattaccatg gtgatgcggt tttggcagta catcaatggg cgtggatagc      420

ggtttgactc acggggattt ccaagtctcc accccattga cgtcaatggg agtttgtttt      480

ggcaccaaaa tcaacgggac tttccaaaat gtcgtaacaa ctccgcccca ttgacgcaaa      540

tgggcggtag gcgtgtacgg tgggaggtct atataagcag agctctctgg ctaactagag      600

aacccactgc ttactggctt atcgaaatta atacgactca ctatagggag acccaagctt      660

ggtaccgagc tcggatccgc caccatgttc caggacgcct acaacgctgc tggaggacac      720

aacgccgtgt tcggcagcgg agctaccaac ttttccctgc tgaagcaggc tggcgatgtg      780

gaggagaacc ccggataagc ggccgctcga gcatgcatct agagggccct attctatagt      840

gtcacctaaa tgctagagct cgctgatcag cctcgactgt gccttctagt tgccagccat      900

ctgttgtttg cccctccccc gtgccttcct tgaccctgga aggtgccact cccactgtcc      960

tttcctaata aaatgaggaa attgcatcgc attgtctgag taggtgtcat tctattctgg     1020

ggggtggggt ggggcaggac agcaaggggg aggattggga agacaatagc aggcatgctg     1080

gggatgcggt gggctctatg g                                               1101


<210>  4
<211>  1179
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  [0022]	DNA sequences of the CMV promoter, 85B epitope, peptide 
       2A, AIP-C5 peptide, and BGH polyadenylation signal

<400>  4
gacattgatt attgactagt tattaatagt aatcaattac ggggtcatta gttcatagcc       60

catatatgga gttccgcgtt acataactta cggtaaatgg cccgcctggc tgaccgccca      120

acgacccccg cccattgacg tcaataatga cgtatgttcc catagtaacg ccaataggga      180

ctttccattg acgtcaatgg gtggactatt tacggtaaac tgcccacttg gcagtacatc      240

aagtgtatca tatgccaagt acgcccccta ttgacgtcaa tgacggtaaa tggcccgcct      300

ggcattatgc ccagtacatg accttatggg actttcctac ttggcagtac atctacgtat      360

tagtcatcgc tattaccatg gtgatgcggt tttggcagta catcaatggg cgtggatagc      420

ggtttgactc acggggattt ccaagtctcc accccattga cgtcaatggg agtttgtttt      480

ggcaccaaaa tcaacgggac tttccaaaat gtcgtaacaa ctccgcccca ttgacgcaaa      540

tgggcggtag gcgtgtacgg tgggaggtct atataagcag agctctctgg ctaactagag      600

aacccactgc ttactggctt atcgaaatta atacgactca ctatagggag acccaagctt      660

ggtaccgagc tcgatatcgg atccgccacc atgttccagg acgcctacaa cgctgctgga      720

ggacacaacg ccgtgttcgg cagcggagct accaactttt ccctgctgaa gcaggctggc      780

gatgtggagg agaacccagg acctgctgct caggctgctg tggtgaggtt tcaggaggcc      840

gctaacaagc agaagcagga gctggactaa gcggccgcga tatctcgagc atgcatctag      900

agggccctat tctatagtgt cacctaaatg ctagagctcg ctgatcagcc tcgactgtgc      960

cttctagttg ccagccatct gttgtttgcc cctcccccgt gccttccttg accctggaag     1020

gtgccactcc cactgtcctt tcctaataaa atgaggaaat tgcatcgcat tgtctgagta     1080

ggtgtcattc tattctgggg ggtggggtgg ggcaggacag caagggggag gattgggaag     1140

acaatagcag gcatgctggg gatgcggtgg gctctatgg                            1179


